2[1]Yang L,Parkin DM,Li LD,et al.Estimation and projection of the national profile of cancer mortality in China: 1991-2005.Br J Cancer.2004,90:2157-2166.
3[2]Turek LP,Smith EM.The genetic progran of genital human papillomaviruse in infection and cancer.Obstet Gynecol Clin North Am,1996,23: 735-758.
4[3]Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resouree settings.Natl Cancer Inst,2000,92:818-822.
5[5]Bekkers RL,Massuger LF,Bulten J,et al.Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer.Rev Med Virol,2004.14:95-105.
6[6]Jacobs MV,Walboomers JM,Snijders PJ,et al.Distribution of 37 mucosotropic HPV types in women with cytologycally normal cervical smear:The age-related patterns for high-risk and low-risk Types.Int J Cancer,2000,87:221-227.
7[7]Kjaer SK,wan den Brule AJC,Bock JE,et al.Human papillolmavirus: the most significant risk determinant of cervical intraepithelial neoplasia.Int J Cancer,1996,65: 601-660.
8[8]Kjaer SK.Type specific persistence of high risk human papillomavirus(HPV)as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.BMJ,2002,325:572-578.
9[9]Green S,Walter P,Kumar V,et al.Human oestrogen receptor cDNA:sequence,expression and homology to v-erb-A.Nature,1986,320(6058):134-139.
10[10]Nobbenhuis MA,Walboomers JM,Helmerhorst TJ,et al.Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.Lancet,1999;354:20-25
